Population-based seroprevalence of prior infection with COVID-19 in Canada: implications for testing, economic revitalization and population health.

  • Funded by Alberta Innovates, Canadian Institutes of Health Research (CIHR)
  • Total publications:7 publications

Grant number: 172723

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2020
  • Known Financial Commitments (USD)

    $716,770.5
  • Funder

    Alberta Innovates, Canadian Institutes of Health Research (CIHR)
  • Principle Investigator

    Pending
  • Research Location

    Canada, Americas
  • Lead Research Institution

    Canadian Blood Services (Ottawa)
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    Gender

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Canadian Blood Services blood donors are healthy people from cities and smaller urban areas in all provinces in Canada except Quebec. Left over blood samples from blood donations will be randomly selected and tested for antibodies to COVID-19. Antibodies are part of the body's response to an infection and are specific for the infecting virus. The presence of antibodies to COVID-19 means that the person previously had COVID-19. They may or may not have immunity to prevent them from getting COVID-19 again (that is, have functional immunity). Over 12 months, 1,500 samples will be tested each month. All samples that test positive for COVID-19 antibodies will have additional testing to measure the antibody concentration (titer) and how effective the antibodies are at binding to COVID-19 virus (neutralization). These will help to understand how likely people who had COVID-19 are to have immunity against re-infection. Tests that can be used for large numbers of samples will be compared to help Canada develop tests suitable for large scale testing. Monitoring functional immunity over the course of the pandemic will help to understand if people start to lose their immunity over time. Monthly data reports will be made available to public health staff (federal and provincial) to inform policy over the course of the pandemic. Mathematical modelling will refine estimates of immunity in the population which is fundamental to public health policy formulation.

Publicationslinked via Europe PMC

Last Updated:39 minutes ago

View all publications at Europe PMC

Character Strengths in the Life Domains of Work, Education, Leisure, and Relationships and Their Associations With Flourishing.

The Relationships of Team Role- and Character Strengths-Balance With Individual and Team-Level Satisfaction and Performance.

Co-occurrence Patterns of Character Strengths and Measured Core Virtues in German-Speaking Adults.

Does the Excellent Enactment of Highest Strengths Reveal Virtues?